PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market ... PR Newswire (press release) The Indian NSCLC market has been especially difficult for drug companies to penetrate, and the market revolves almost exclusively around generics. The market is dominated by generic chemotherapies including pemetrexed (Alimta) as well as the generic ... |
